Craniopharyngioma epidemiology and demographics

Revision as of 15:11, 26 February 2019 by Marjan Khan (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Craniopharyngioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Craniopharyngioma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Craniopharyngioma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Craniopharyngioma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Craniopharyngioma epidemiology and demographics

CDC on Craniopharyngioma epidemiology and demographics

Craniopharyngioma epidemiology and demographics in the news

Blogs on Craniopharyngioma epidemiology and demographics

Directions to Hospitals Treating Craniopharyngioma

Risk calculators and risk factors for Craniopharyngioma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Marjan Khan M.B.B.S.[2]

Overview

The demographic patterns of craniopharyngioma are not well described because the tumor is rare. In addition, most cancer registries collect data only on malignant conditions and, therefore, they are not useful in the study of craniopharyngioma which is considered to be a borderline histological malignancy. Incidence rates are similar in males and females and between caucasians and African Americans. Tumors are more common among children of age 5 to 15 years and older adults of greater than 65 years, while the lowest rates occur among those aged 15 to 34 years. Survival is highest for patients diagnosed at a younger age.

Epidemiology and demographics

Prevalence

Incidence

  • The overall incidence of craniopharyngioma is approximately 0.5 to 2 per 100,000 per year.[1]
  • The age distribution is bimodal with a peak in childhood and a second peak among middle-aged and older adults.[1]
  • No definite genetic relationship has been found and few familial cases reported. [1]

Age

Gender

  • There appears to be a similar incidence in both males and females.[3]

Race

  • No racial predilection is seen in craniopharyngioma cases.
  • Few studies show that there is a higher incidence rates reported in Japan and some parts of Africa. [1]

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM (October 1998). "The descriptive epidemiology of craniopharyngioma". J. Neurosurg. 89 (4): 547–51. doi:10.3171/jns.1998.89.4.0547. PMID 9761047.
  2. Incidence. Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM. Pubmed. http://www.ncbi.nlm.nih.gov/pubmed/9761047
  3. Epidemiology. Dr Dylan Kurda and Dr Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/craniopharyngioma


Template:WikiDoc Sources